Radioimmunotherapy, Gemcitabine combination shows early guarantee for metastatic pancreatic ductal malignancy

A combination of several small doses of an investigational radioimmunotherapy and the radiation treatment gemcitabine had superior outcomes compared with radioimmunotherapy alone in patients along with metastatic pancreatic ductal cancer, based on phase Ib clinical trial data presented at the AACR special conference on Pancreatic Cancer: Innovations within Research and Treatment, held Might 18-21. Related Posts:Fox Chase trial tests promising therapy in early breast…New nanopharmaceutical may help overcome resistance to…Analysis tackles liver transplant failureFeasible, safe to limit radiation in order to major salivaryNew IBS treatment shows possible in Phase 2 researchThe post Radioimmunotherapy, Gemcitabine combination shows early guarantee for metastatic pancreatic ductal malignancy appeared first on My Irritable Bowel Syndrome Story.
Source: My Irritable Bowel Syndrome Story - Category: Other Conditions Authors: Tags: IBS News Source Type: blogs